FDA NDA · NDA005795

FURACIN

Sponsor: SHIRE

APPLICATION

NDA005795

TYPE

NDA

ORIGINAL APPROVAL

1945-10-04

LATEST ACTION

2000-02-09

ROUTE

TOPICAL

DOSAGE FORM

OINTMENT

MARKETING STATUS

Discontinued

Products

FURACINDiscontinued

NITROFURAZONE 0.2% · OINTMENT · TOPICAL

2000-02-09Manufacturing (CMC) · Supplement 13 · standardAP

1998-09-21Manufacturing (CMC) · Supplement 11 · standardAP

1998-09-21Manufacturing (CMC) · Supplement 12 · standardAP

1986-06-09Manufacturing (CMC) · Supplement 9 · standardAP

1984-06-12Labeling · Supplement 7 · standardAP

1982-05-26Manufacturing (CMC) · Supplement 8 · standardAP

1982-02-17Labeling · Supplement 6 · standardAP

1980-09-12Manufacturing (CMC) · Supplement 5 · standardAP

1979-07-11Manufacturing (CMC) · Supplement 4 · standardAP

1978-01-12Manufacturing (CMC) · Supplement 3 · standardAP

1945-10-04Type 3 - New Dosage Form · Original · standardAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.